Topic Compatibility Lactoserum (Dermacyd Delicata - New Fragrance)

Sanofi

Status and phase: Completed; Phase 4

Conditions: Hygiene

Treatments: Drug: Lactoserum

Study type: Interventional

Funder types: Industry

Identifiers

NCT00497692

LACTO_L_02948

Details and patient eligibility

About

The purpose of this study is to demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd Femina Delicata.

Enrollment: 30 estimated patients

Sex: Female

Ages: 18 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Phototypes: I, II, III and IV
• Integral skin test in the region

Exclusion criteria

• Pregnancy or breastfeeding women
• Use of antinflammatory or immune-suppression drugs
• Personal history of atopy
• History of sensibilization or irritation for topic products
• Active cutaneous disease
• Use of new drugs and/or cosmetics during the study

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)